The FDA granted approval of Dovato to ViiV Healthcare
The U.S. Food and Drug Administration Monday approved Dovato, two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.
Pharmaceuticals, Biotechnology and Life Sciences
The U.S. Food and Drug Administration Monday approved Dovato, two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.
Tricida has closed public offering of common stock and full exercise of underwriters’ option to ourchase additional shares
Unprecedented clinical results for DaxibotulinumtoxinA for Injection(DAXI), Revance’s long-acting neuromodulator, were highlighted at the 17thAesthetics & Anti-Aging Medical World Congress in Monte-Carlo
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after…
United Therapeutics Corporation Monday said that the BEAT clinical study of esuberaprost tablets in patients suffering from pulmonary arterial hypertension did not meet its primary endpoint of delayed time to first clinical worsening event.
Azitra will be presenting results from the joint researchshowing the successful genetic engineering of the common skin bacterium, Staphylococcusepidermidis, to produce high levels of functional LEKTI protein, aprotease inhibitor involved in regulating the rate of skin loss.
SAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a San Francisco based technology company and Pharmacy Benefit Manager (PBM), today released the company’s public comment…
The new treatment can potentially provide benefits superior to other commontherapies greatly improving clinical outcomes for patients being treatedfor lung cancer.
DUBLIN–(BUSINESS WIRE)–The “Cough – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Cough – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “eClinical Solutions Market Size, Share & Trends Analysis Report By Product (CTMS, ECOA, EDC, CDMS, RTSM, eTMF), By…